INFORMATION BY CANCER TYPE
General financial topics
The newly approved CAR T-cell therapy, Kymriah (tisagenlecleucel), is being put on the market with a price tag of $475,000 for a single infusion, which is within the range that oncologists predicted.
Even cancer patients with insurance face difficulties with financial toxicity.
“If you locked everybody in a room for a week, I think we could come up with something that everybody would be comfortable with,” said Blase Polite, M.D., a co-author of the statement, and immediate past chair of ASCO’s government relations committee.
Just because Senate leaders say it's a good health care plan, is it really?
Reforms are needed high up within the drug distribution chain, concluded a panel of pharmaceutical professionals at the Oncology Market Access & Pricing conference held in Philadelphia this week by eyeforpharma.
The new GOP health care bill is causing concern for those suffering pre-existing medical conditions. How will it affect those with cancer?
How I saved big on costly prescription medications for cancer treatment.
The American Health Care Act has been passed by a vote of 217 to 213.
Can President Donald Trump be more successful in lowering drug prices than he was in repealing and replacing the Affordable Care Act?
Choosing a prosthesis requires a little work on the part of the wearer. Understanding options is not only helpful, but necessary.